Quantum Biotech Completes the Cure for All Cancer!

Did you see the truly amazing news that there’s now a drug that can actually cure all cancers no matter their location? And it’s been approved by the fusty old FDA so it really must work! Yep, it only works in about 4% of the population who have the right genetic makeup. But the writing is on the wall. Soon scientists are going to figure out all the main clusters of genetic markers for different cancers so gradually the cure will extend to almost all of the population. How long? 10 years? BTW the drug is marketed under the Keytruda name.

You might think that’s a wildly over-optimistic prediction. Even if the boffins have managed to find a cure for cancer for 4% of the population, it’s going to be a huge stretch to extend that to everyone else given the complexities of DNA and genetic structures. Maybe there’s another century of work there to crack those codes, if not more.

I’ve blogged recently on how quantum approaches and computers are poised to change everything, soon (“Quantum is the new digital”). Quantum computers already exist although they are kind of “primitive” as yet. Confidently expect that to change soon. The quantum age is about to be on us.

Developing the cure for all cancers is going to be one of the most computationally intensive tasks ever undertaken by humans. Just in tithe nick of time, quantum computers are coming along to join the fight. Computational biotech is about to emerge as the answer to research oncologists. There just gonna have to do a little brushing up on the quantum physics, that’s all. If not also their quantum biology.

So what might have been seen as a computationally impossible task has now metamorphosed into one that is computationally possible, if still daunting. But quantum biotech is going to provide the answer.

Of course, curing cancer within a decade is a huge thing in and of itself. But believe it or not, that’s going to be the least of the achievements we can expect from the soon-to-emerge field of quantum biotech.

There’s still a lot of unfinished business out there. Start off with Alzheimer’s. Then the lifestyle ailments such as heart disease and obesity. Not to mention emerging pathogens such as Zika, and Ebola. Of course there’s still that unfinished business with of HIV, no matter the huge progress that’s been made so far.

Quantum biotech has the potential to provide the computational horsepower to solve all these diseases. Sure, there’s going to be a need for conceptual breakthroughs that led to the development of Keytruda in the first place.

The current unspoken medical model for the “incurable” diseases such as HIV and most cancers is to see them as being chronic rather than fatal diseases. Of course, that’s progress, especially if you are the patient. This is the palliative model of care. Quantum biotech opens up the possibility that we can transform the model to being purely curative rather than palliative.

There’s been an understandable tendency to see the attainment of immortality as being in the same class of problems as perpetual motion.

It’s starting to look like quantum biotech to could bring immortality into the class of soluble problems.

Then we’ve really got a problem.